Skip to main content
Premium Trial:

Request an Annual Quote

Applied Markets Watch: Life Tech Forensic DNA Quantification Kits; InstantLabs Food Safety Assays


Life Technologies, a Thermo Fisher Scientific brand, recently launched two new DNA quantification kits for forensics applications.

The Quantifiler Trio and Quantifiler HP (Human Plus) kits enable forensic scientists to screen samples more efficiently and better discriminate between human and non-human DNA. In addition, the Quantifiler Trio kit features an improved male target for increased quantitation reliability in excess amounts of female DNA, commonly seen in sexual assault samples.

When paired with the company's HID Real-Time PCR Analysis v1.2 software, the kits help drive well-informed workflow decisions before proceeding to STR analysis, Life Tech said.

Life Tech also introduced the HID-Ion AmpliSeq Identity Panel. Developed in collaboration with leading forensic scientists, the panel enables researchers to identify degraded samples in 1.5 days from as little as 1 nanogram of input DNA. Run on the Ion PGM system, the HID-Ion AmpliSeq Identity Panel enables 50 or more samples to be multiplexed, with sample specificity and low match probabilities comparable to a 13-core CODIS STR set.

InstantLabs said this month that it has completed AOAC certifications for food safety kits designed to detect the most important food pathogens — Salmonella, Escherichia coli O157, Listeria spp., and Listeria monocytogenes — from a variety of food matrices.

The AOAC Performance Tested certification mark is widely recognized by the global food industry and government agencies and is awarded to products that have passed unbiased and rigorous evaluation. The AOAC previously approved InstantLabs Food Safety Kits for Salmonella, Listeria spp. and L. monocytogenes. Instantlabs also offers porcine and equine species identification tests.

InstantLabs' tests run on the company's Hunter real-time PCR platform.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.